drugset / Trial / NCT01005108

Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors

NCT01005108 ↗

Phase 2 Completed 120 enrolled Abramson Cancer Center at Penn Medicine
RandomizedParallel-groupTriple-blindTreatment

Summary

Overall Objectives: The overarching goal is to compare the effectiveness of acupuncture and gabapentin to their respective placebo controls in the treatment of hot flashes in breast cancer patients. The investigators primary specific aim will focus on determining the magnitude of response to placebo acupuncture versus placebo pills on hot flashes (HFs).

Timeline

Start
2009-01
Primary completion
2014-01-31
Completion
2014-01-31

Outcome

Met primary endpoint

paper SA produced significantly greater reduction in HFCS than did PP (-2.39; 95% CI, -4.60 to -0.17). PMID 26304905 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Unknown 900 mg —

Indications

No indication recorded.